CONTRAST-INDUCED NEPHROPATHY IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE AND ONE YEAR PROGNOSIS
Keywords:
contrast-induced nephropathy, contrast-associated acute kidney injury, coronary heart disease, percutaneous coronary intervention, contrast agent, prognosisAbstract
The purpose of the study was to determine the incidence of contrast-induced nephropathy (CIN) in patients with chronic ischemic heart disease (CHD) and the prognostic significance of CIN within 1 year. 462 patients suffering from stable CAD and having indications for studies with intra-arterial administration of iodine-containing contrast agent were examined. The study was a prospective open cohort study and was registered in the ClinicalTrials system. Gov. under ID number NCT04014153. The primary endpoint was the development of CIN. Secondary end points were overall mortality, cardiovascular mortality, development of myocardial infarction, stroke, gastrointestinal bleeding (GIB), acute decompensation of chronic heart failure (CHF), coronary artery bypass grafting (CABG), repeat percutaneous coronary intervention (PCI). ).
References
Caspi O, Habib M, Cohen Y, Kerner A, Roguin A, Abergel E, et al. Acute Kidney Injury After Primary Angioplasty: Is Contrast-Induced Nephropathy the Culprit? J Am Heart Assoc. 2017;6(6):1–10.
James MT, Ghali WA, Tonelli M, Faris P, Knudtson ML, Pannu N, et al. Acute kidney injury following coronary angiography is associated with a long-term decline in kidney function. Kidney Int [Internet]. 2010;78(8):803–9.
Jumayeva M.F., Predictors Of The Development Of Hepatorenal Syndrome. Problems biology and medicine. 2022 № 6 (140) p.80-82
Jumaeva M.F., Hepatorenal Syndrome. Asian journal of Pharmaceutical and biological research. Volume 11 Issue 3 SEPT.-DEC. 2022 p.72-77
Jumayeva M.F. Hepatocardiorenal syndrome . Asian journal of Pharmaceutical and biological research. Volume 11 Issue 1 JAN-APR 2022 p.
Lakhal K, Robert-Edan V, Ehrmann S. In the Name of Contrast-Induced Acute Kidney Injury…. Chest [Internet]. 2020;157(4):751–2
Mustafayeva M.R.Contrast-induced nephropaty . Focus on prevention. Asian journal of Pharmaceutical and biological research. Volume 11 Issue 1 JAN-APR 2024 p.
Mustafayeva M.R. Kontrastli indusirlangan nefropatiya. Profilaktik chora-tadbirlar. Central Asian journal of education and innovation. Vol. 2, Issue 6, Part 6 June 2023.
Sharipovna, A. N., Tulkinzhanovna, S. G., Hayatovna, M. M., & Odiljonovna, G. N. (2021). Analysis of the results of a study on the frequency of occurrence and prevalence of risk factors for chronic kidney disease. International Journal of Current Research and Review, 13(2), 127-131.
Solomon R. The role of osmolality in the incidence of contrast-induced nephropathy: a systematic review of angiographic contrast media in high risk patients. Kidney Int [Internet]. 2005;68(5):2256–63.
Thomsen HS, Morcos SK, Barrett BJ. Contrast-induced nephropathy: The wheel has turned 360 degrees. Acta radiol. 2008;49(6):646–57.
Weisbord SD, Chen H, Stone RA, Kip KE, Fine MJ, Saul MI, et al. Associations of increases in serum creatinine with mortality and length of hospital stay after coronary angiography. J Am Soc Nephrol. 2006;17(10):2871–2877.
